Pharmaceuticals Omicron BA.4/BA.5 – adapted bivalent vaccineBy AndyOctober 13, 20220 Pfizer Inc. and BioNTech SE has announced early data from a Phase 2/3 clinical trial evaluating the safety, tolerability, and immunogenicity of…
Pharmaceuticals Pfizer Completes Acquisition of Global Blood TherapeuticsBy AndyOctober 6, 20220 Pfizer Inc. has announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the…
